The European Commission (DG Research – Directorate Health) organized an Open Information Day on FP7 Health research on 8th of June 2010, in Brussels. Leyla Arsan, the CEO of TAGES, and Cem Bozkurt, the CEO of Alvimedica Medical Technologies, participated to Open Information Day & Brokerage Event.
European Commission will open a new call on FP7 Health theme on July 2010. In order to provide more information on the call, the Commission organised an information day in Brussels on the 8th of June 2010. The event which was organised in cooperation with various programmes such as HEALTH-NCP-NET, SMEsgoHEALTH, SM BioPower, Kappa Health, and EEN aimed to highlight the priorities, novelties and special features of the 2011 Work Programme. The details of the next health call such as the final version of the 2011 Work Programme to be published in July 2010 through two calls for proposals (single-stage and two-stage) were stated.
The Work Programme of FP7 Health Call foresees major efforts in brain-related diseases, diabetes and obesity, immunisation, epigenomics and social determinants of health, as well as other global health issues, such as anti-microbial drug resistance and emerging epidemics. Cross-cutting features of the 2011 Work Programme include a number of topics for clinical trials and SME-targeted topics that foresee a major role for the SME(s) involved in each project. The call is estimated to have a total budget of approximately € 650 million. Proposals will be evaluated in late 2010 and early 2011.
The programme consists of plenary sessions and several parallel sessions on participating in the FP7 ‘Health’ theme, including:
- Overview of FP7 Health and draft Work Programme 2011
- Participating in an EU funded project: Challenges and opportunities
- Strategic planning for SMEs
- Focus on clinical trials
- High Impact Research Initiative
- Research without borders / International Cooperation
- Participating in an EU funded project: Steps to success
- Satellite workshop Coordinating Health Research Communication
The participants presented their organisation’s expertise and specific interest in cooperation with international partners in the Health sector under Brokerage Event where 133 participants participated. Bilateral meetings were organized in the afternoon, 16:00-18:00. Totally 118 bilateral meetings were implemented to discuss the possibilities of cooperation and formation of potential project consortia on the larger scale. Leyla Arsan, the CEO of TAGES, met Zofia Bilinska from Institute of Cardiology (Poland) and Cem Bozkurt, the CEO of Alvimedica Medical Technologies, met Camelia Dijkstra from Coventry University (United Kingdom) and Jonas Algis Abaravicius from Vilnius University faculty of Medicine (Lithuania) to discuss on further partnership opportunities in new Health projects.
Researchers and entrepreneurs also presented their project ideas for the Health Theme in FP7 in “Flash Presentations”. Arsan and Bozkurt made a presentation in different parallel sessions on Multi Drug Stent Coating for the Treatment of Cardiovascular Disease which is a project idea of Alvimedica.. The proposal intends to study the development of covalently anchored drugs on a coronary stent of various materials and clinical outcome of the release profiles and Alvimedica is seeking for partners to conduct clinical and animal studies in the proposal.
The event became useful that the participants have come together to discuss potential collaborative project ideas. The next step of project proposal preparations is waiting for the publishment of the final version of the 2011 Work Programme and the opening of the call.
For more information on the FP7 Health Call, please see: http://ec.europa.eu/research/health/events-02_en.html
